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Site-directed spin-labelingKL4, which has demonstrated success in the treatment of respiratory distress, is a synthetic helical, amphipathic
peptide mimetic of lung surfactant protein B. The unusual periodicity of charged residues within KL4 and its
relatively high hydrophobicity distinguish it from canonical amphipathic helical peptides. Here we utilized site
speciﬁc spin labeling of both lipids and the peptide coupled with EPR spectroscopy to discern the effects of KL4
on lipid dynamics, the residue speciﬁc dynamics of hydrophobic regions within KL4, and the partitioning depths
of speciﬁc KL4 residues into the DPPC/POPG and POPC/POPG lipid bilayers under physiologically relevant condi-
tions. KL4 induces alterations in acyl chain dynamics in a lipid-dependent manner, with the peptide partitioning
more deeply into DPPC-rich bilayers. Combined with an earlier NMR study of changes in lipid dynamics on addi-
tion of KL4 (V.C. Antharam et al., 2009), we are able to distinguish how KL4 affects both collective bilayermotions
and intramolecular acyl chain dynamics in a lipid-dependent manner. EPR power saturation results for spin la-
beled lipids demonstrate that KL4 also alters the accessibility proﬁles of paramagnetic colliders in a lipid-
dependentmanner. Measurements of dynamics and depth parameters for individual spin-labeled residueswith-
in KL4 are consistent with a model where the peptide partitions deeply into the lipid bilayers but lies parallel to
the bilayer interface in both lipid environments; the depth of partitioning is dependent on the degree of lipid acyl
chain saturation within the bilayer.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Pulmonary surfactant (PS) is a vital, lipid-rich extracellular ﬂuid that
lowers surface tension and provides immunoprotection within the
alveoli. PS is comprised of a mixture of phospholipids and proteins,
with the major lipid component being 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC). Low concentrations of hydrophobic proteins
within PS are critical to its unique physical properties and lipid trafﬁck-
ing functions including the following: facilitating lung expansion at am-
bient pressure, preventing alveolar collapse, and signiﬁcantly reducing
surface tension in a highly dynamic, organized process [1–3]. Inade-
quate PS production in premature infants is the leading cause of acutentproteinB;MLV,multilamellar
-palmitoyl-2-oleoyl-sn-glycero-
lycero-3-phosphatidylglycerol;
n-doxyl-PSPC, 1-palmitoyl-2-
tide/lipid molar ratio; CD, circu-
copy; SDSL, site-directed spin
resonance; ΔHpp, peak-to-peak
roxyethyl)amino]-2-(hydroxy-
tonate; NiEDDA, nickel (II)
itoyl-2-stearoyl-sn-glycero-3-
labelrespiratory distress syndrome (ARDS), [4–6] where typical treatment
is the administration of exogenous, animal-derived PS via the airways
[7,8]. The reliance on these biologically sourced surfactants is due to
the difﬁculty in recombinant expression and puriﬁcation of the highly
hydrophobic surfactant proteins critical to PS function, particularly
surfactant protein B (SP-B). Failure to produce functional SP-B leads to
respiratory failure and eventual death [9].
Synthetic, peptide-based lung surfactant replacement therapies for
RDS therapy have shown promise and can potentially reduce the cost
and immunologic risks associated with exogenous animal-derived PS.
Functional studies have shown that much of the action of SP-B can be
recaptured using peptides 20–25 amino acids in length based on the
N- and C-termini of SP-B [10–12]. KL4, is a 21-mer peptide mimetic of
the C-terminus of SP-B, of sequence KLLLLKLLLLKLLLLKLLLLK, and it
was designed based on the charge distribution and hydrophobicity of
the native protein sequence [13]. KL4 has demonstrated efﬁcacy for
treatingARDSwhen formulatedwith palmitic acid and lipids commonly
found in PS [14,15]. This formulation, termed Lucinactant, was recently
approved for the prevention of RDS in high risk premature infants [16].
Although KL4 is a promising replacement of SP-B in the treatment for
RDS, itsmechanismof action remains controversial. The increased effec-
tiveness of KL4when compared to other clinically available formulations
[17,18] and its greatly simpliﬁed amino acid sequence suggest that an
understanding of its structural properties and its effects on the molecu-
lar and biophysical properties of the lipids could yield fundamental
3213A.L. Turner et al. / Biochimica et Biophysica Acta 1838 (2014) 3212–3219insights into peptide/lipid interactions for the rational design of novel
synthetic mimetics.
Low resolution structural characterization of KL4 in lipid environ-
ments via CD and FTIR has consistently indicated the formation of a
helical peptide conformation in lipid suspensions; although some varia-
tions in helicity with lipid composition have been reported [19,20]. Ex-
perimental characterizations of the orientation of KL4 have yielded
inconsistent, conﬂicting results. In early FTIR work using DPPC/DPPG
(7:3) bilayers, KL4 was found to be helical and spanning the bilayer in
a transmembrane orientation [21]. Later FTIR work, using either DPPC
or DPPC/DPPG (7:3) mixtures, indicated that KL4 lies along the surface
of the lipids as a mixture of β-sheet and α-helix at the air/water inter-
face [22]. However, these lower-resolution assays monitored amide I
stretching frequencies, which can be solvent dependent [23], and as-
sumed that KL4 adopts classicalβ-sheet orα-helix secondary structures.
A more recent transcription–translation assay found KL4 capable of tra-
versing lipid bilayers, suggesting a transmembrane orientation [24].
However, this transcription–translation assay relied on the integration
of a DNA sequence encoding KL4 into the Escherichia coli inner mem-
brane protein leader peptidase (Lep) gene, translation of the protein
at ER-derived microsomal membranes, and assaying for glycosylation
using proteinase K to determine whether the peptide traverses the
membrane. This type of host–guest experiment may inﬂuence the
secondary structure of KL4 in the lipid bilayers, and KL4 is known to
alter lipid dynamics and trafﬁcking, which may affect the overall integ-
rity of the microsomal membranes.
A possible explanation for these mixed results may lie in a detailed
investigation of the exact helical nature of KL4. Interestingly, the occur-
rence of lysines at every ﬁfth residue in KL4 prevents a simple amphi-
pathic helical wheel prediction for the structure and orientation of KL4
in a lipid environment; nevertheless, this lysine pattern was found to
convey maximal surface activity [25]. A helical wheel projection of the
KL4 sequence assuming a canonical α-helical conformation reveals a
side chain distribution that is at oddswith partitioning of an amphipath-
ic peptidewithin the plane of lipid bilayers in amembrane environment
(Fig. 1A). Speciﬁcally, the canonical α-helical pitch does not produce a
signiﬁcant hydrophobic moment nor impart amphipathic characteris-
tics to the peptide. The KL4 sequence also does not contain a long
enough hydrophobic segment to traverse the membrane, i.e. a trans-
membrane orientation of the peptide would bury 2–3 charged lysine
side chains in the hydrophobic interior of the membrane. Previously,
we have characterized the structure of KL4 in POPC/POPG (3:1) lipid bi-
layers via solid state NMR spectroscopy and found that it adopts a struc-
ture that is helical yet more amphipathic thanwould be predicted by an
α-helical conformation [20]. As depicted in Fig. 1B and C, structural
models derived fromNMRdata of KL4 in twodifferent lipid environmentsBA
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Fig. 1. Helical wheel plots of KL4 with varying pitch. Wheels generated (A) assuming a canonic
POPG vesicles (4.1 residues/turn) [20]; and (C) using the average torsion angles suggested by pr
the net hydrophobic moments resulting from the distribution of charged lysine sidechains on t
N-terminus is less structured relative to the rest of the helix. Leucines successively substitutedexhibit a helical pitch of N4 residues/turn, in contrast to a canonical
α-helix with 3.6 residues/ turn.
In order to more directly probe the insertion depth of KL4 at the
residue level, to characterize the effects of KL4 on lipid dynamics on a
nanosecond rather than microsecond timescale, and to determine the
effects of KL4 on solvent penetration into the lipid bilayers, we utilized
site-directed spin labeling (SDSL) and EPR spectroscopy to examine
the interaction of KL4 with DPPC/POPG and POPC/POPG lipid vesicles.
The use of power saturation experiments to generate a more quantita-
tive, residue-speciﬁc partitioning proﬁle for membrane-associated pro-
teins is well-established [26], and yields information that is highly
complimentary to our previous NMR studies [27,28]. By analyzing EPR
line shapes and paramagnetic accessibility in a site-speciﬁc manner,
we are developing a comprehensive model of the membrane bound
orientation of KL4, thus providing structural insights into itsmechanism
of action in restoring PS function and directing future rational develop-
ment of more active SP-B peptidomimetics.
2. Materials & methods
2.1. Materials
POPC, DPPC, POPG, n-doxyl-PSPC (where n = 5, 7 and 12) and
TEMPO-PC were purchased as chloroform solutions from Avanti Polar
Lipids (Alabaster, AL) and quantiﬁed by phosphate analysis (Bioassay
Systems, Hayward, CA). Iodoacetamido-PROXYL spin label (IAP) was
purchased from Sigma (St. Louis, MO) and used as received. Unless
otherwise stated, all other reagentswere purchased fromFisher Scientiﬁc
(Hampton, NH) and used as received.
2.2. Synthesis of KL4
KL4, (KLLLLKLLLLKLLLLKLLLLK) was synthesized via solid-phase
peptide synthesis (ICBR Facility, UF), puriﬁed by RP-HPLC, and veriﬁed
bymass spectrometry (m/z= 2469). Peptidewas dissolved inmethanol
and analyzed by amino acid analysis for concentration (Molecular Struc-
ture Facility, UCDavis). Eight cysteine variants of KL4, inwhich individual
leucineswere replaced by cysteinewere also synthesized via solid-phase
peptide synthesis (SPPS), puriﬁed, and mass veriﬁed (m/z = 2459).
2.3. Spin-labeling of KL4 cysteine mutants
Cysteine containing KL4was dissolved in aminimal amount of King's
reagent [29] and ether precipitated to ensure that the cysteine was
reduced prior to spin labeling. The peptide was then dissolved at a con-
centration of ~0.1 mM inMeOH and KOHwas added to adjust the pH toC
K
K
K
L
L
4.09
L
L
L
L
L
L
.03
K
L7L
L8
K
L12
L
L
L
L13
L9 L9
L13
L8
L12
L7KL
L15
L
L
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eliminary NMR experimentswith DPPC/POPG vesicles (4.6 residues/turn). Arrows indicate
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with cysteine for SDSL-EPR experiments in this work are shown in gray crosshatch.
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added to keep the cysteine reduced. An appropriate volume of stock so-
lution of 50 mM IAP spin label in DMSO was added to achieve a 20-fold
excess of spin label to peptide. After being allowed to react in the dark
for 4–5 h at room temperature, the spin-labeled peptide was puriﬁed
via HPLC, and lyophilized fractions were solubilized in MeOH. The
ﬁnal peptide concentration for each spin-labeled sample was deter-
mined by either analytical HPLC or amino acid analysis (AAA).2.4. Preparation of lipid/peptide samples
Lipid mixtures were prepared by mixing appropriate volumes of
stock lipid chloroform solutions. For samples containing peptide, the
peptide was added as a methanol solution to the lipid mixture in chlo-
roform. Organic solvents were evaporated under nitrogen and the
lipid ﬁlms were re-suspended in warm cyclohexane (~45 °C), ﬂash
frozen and lyophilized. For each combination of lipids and peptide,
two separate samples were prepared. The ﬁrst was rehydrated with
140 mM NaCl, 10 mM Bis–Tris buffer, pH 6.5, and the second was
rehydrated with 140 mMNaCl, 10 mM Bis–Tris buffer, pH 6.5, contain-
ing 10 mM NiAA (concentration adjusted and veriﬁed by UV–VIS ab-
sorption). The hydrated dispersions were subjected to N5 freeze–thaw
cycles to form uniform MLVs and had 10 mM ﬁnal lipid concentration
of either 4:1 POPC/POPG or 4:1 DPPC/POPG. Samples containing spin-
labeled lipid contained 1 mol% of either n-doxyl-PC (where n = 5, 7
and 12) or tempo-PC relative to the other lipids.2.5. CD experiments
CD spectrawere acquired at 45 °C on anAvivModel 215 (Lakewood,
NJ). Samples were prepared by hydrating lyophilized peptide–lipid
powders in 10mMBis–Tris buffer, pH 6.5, with 140mMNaCl, to achieve
a ﬁnal concentration of 35–50 μM KL4, 2.5 mM lipids, and N5 freeze–
thaw cycles were performed to form uniform MLVs, which were then
extruded through 100 nm ﬁlters (Avanti Polar Lipids, Alabaster, AL)
to form LUVs just prior to data collection. Data were background
subtracted using buffer and lipid control samples.2.6. CW-EPR spectroscopy
CW-EPR spectra were collected on a modiﬁed Bruker ER200 spec-
trometer (Billerica, MA) with an ER023M signal channel, an ER032M
ﬁeld control unit, and a loop gap resonator (Medical Advances, Milwau-
kee,WI). Spectra of samples containing either spin-labeled lipid or spin-
labeled KL4 were recorded at 45 °C. A quartz Dewar (Wilmad-Labglass,
Vineland NF) surrounded the loop gap resonator for variable tempera-
ture experiments. Temperature was controlled by passing nitrogen gas
through a copper coil submerged in a recirculating bath (Thermo
Scientiﬁc) containing 40% ethylene glycol. For CW line shape analyses,
typically a sample volumeof 10 μLwasutilized and spectrawere collect-
ed using a 125G sweep at a 2mWpower level, with 0.8–2Gmodulation
amplitude depending upon the inherent inhomogeneous line width.
LabVIEW software (National Instruments, Austin, TX) was used for
baseline correction and double integral area normalization using rou-
tines generously provided by Drs. Christian Altenbach and Wayne
Hubbell (UCLA, Los Angeles, CA). Spectra were then analyzed for
spin-label mobility in an empirical manner. These empirical line
shape parameters include measuring the peak-to-peak line width
of the central resonance line in the derivative spectrum, ΔHpp, and
the ratio of the central resonance intensity to the lower ﬁeld intensity,
h(0)/h(1), as these parameters correlate with spin-label mobility and
provide characterization of the local environment around the spin
label [30–32].2.7. Power saturation EPR experiments
EPR spectra were collected with parameters described above using
gas-permeable TPX capillary tubes (Molecular Specialties Medical
Advances, Milwaukee, WI) containing ~7–10 μL of sample that was
equilibratedwith either nitrogen gas or air (20% oxygen) until signal in-
tensity no longer changed; typically around 15 min. The peak-to-peak
ﬁrst derivative amplitude, App, of the central resonance (h(0)) wasmea-
sured and plotted as a function of microwave power, P, ranging in inci-
dent power from 0.2–63 mW. The resultant curves were ﬁt to the
expression:
App 0ð Þ ¼ I
ﬃﬃﬃ
P
p
1þ 2−ε−1  P
P1=2
" #−ε
ð1Þ
where I is a scaling factor, P1/2 is the power at which the resonance
amplitude is one-half its unsaturated value, and ε is a measure of homo-
geneity of the saturation of the resonance [26]. P1/2 valueswere obtained
under three conditions for all peptide/lipid samples:
1) Hydrated vesicles equilibrated under nitrogen gas, giving P1/2(N2)
2) Hydrated vesicles equilibrated under air (20% oxygen in compressed
gas), giving P1/2(O2)
3) Hydrated vesicles equilibrated with 10 mM NiAA under nitrogen
gas, giving P1/2(NiAA).
No differences in line shape were noted on addition of NiAA or O2,
hence we did not need to account for ΔHpp line width changes [33–35].
ΔP1/2 values were calculated by subtracting the P1/2(N2) from either
P1/2(O2) or P1/2(NiAA). A depth parameter, Φ, was calculated using the
following formula:
Φ ¼ ln ΔP1=2 O2ð Þ=ΔP1=2 NiAAð Þ
h i
ð2Þ
3. Results
3.1. KL4 secondary structure and spin labeling
Eight leucine positions in KL4 (Fig. 1A) were individually replaced
with cysteine and spin-labeled with IAP to allow analysis of the two
hydrophobic segments at the center of the KL4 sequence; allowing for
the discrimination between a transmembrane or in-plane orientation
of KL4. IAP was utilized in these studies given that work from our lab
on highly dynamic proteins has shown that the resulting S\S bond
formed by theMTSL labeling of the CYS residue can be reduced, compli-
cating CW data analysis due to the sharp signal from the released free
spin-label as well as the possibility of dimerization of protein that can
result from disulﬁde formation. Hence, given our past experiences [32],
the IAP label was chosen. IAP is growing in popularity in the ﬁeld given
this potential problem of disulﬁde exchange when using MTSL labeling.
CD spectra (Supplementary Figure S1), and hence secondary struc-
tures, for six of the eight IAP-cysteine containing KL4 constructs (L7P1,
L8P1, L9P1, L12P1, L13P1 and L15P1; where P1 means the IAP modiﬁed
CYS residue (Fig. 2) exhibited the same level of helicity as native KL4
both in solution and in lipid environments. The EPR data for these six
constructs are presented and are used for analyzing the partitioning of
KL4 into the lipid environments. For two of the constructs (L10P1 and
L14P1) the CD spectra indicated a loss of helicity upon P1 incorporation;
EPR data for these two constructs are provided in the Supplementary in-
formation (S2, S5), but these data were not used in developing the pro-
posed model for KL4 partitioning. Conventional CD ﬁtting analyses
reveal a signiﬁcant degree of helical structure for both native KL4 and
spin-labeled (SL) KL4 constructs when interacting with lipid LUVs.
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the peptide
CW-EPR spectra of each SL-KL4 peptide were collected for the pep-
tide inmethanol aswell as interactingwith the lipid systems of interest.
Spectra obtained for the peptides in methanol have the expected fast
limit nearly isotropic line shapes of small unfolded, soluble peptides
(data not shown). Spectra collected in the presence of either DPPC/
POPG or POPC/POPG are shown in Fig. 2. The mobility of each SL-KL4
site upon partitioning into the two lipid systemswas assessed by empir-
ical line shape analysis. Speciﬁcally,ΔHpp wasmeasured as a function of
spin-label position, and, for all sites investigated here, gave values rang-
ing between 2.9 and 3.8 G (±0.1 G) for membrane bound KL4 (Fig. 2B).
The data shown were collected for a 50:1 L/P ratio, reﬂecting the com-
position of therapeutic Lucinactant which contains 2mol% peptide rela-
tive to the lipids.
Inspection of these data supports two general results. First, spectra
for all SL-KL4 samples exhibit line shapes that are consistent with
restricted motion reﬂective of membrane binding for non-aggregated
helical proteins. The data in Fig. 2 are similar to those observed for inter-
facial orientations of single amphipathic sequences bound tomembrane
interfaces, such as α-synuclein [36], supporting an orientation of KL4
parallel to the plane of the lipid bilayer. Additionally, the degree of mo-
bility reﬂected in the motional averaging of the line shapes is uniformly
higher than what has been observed for spin labels located in buried
sites of soluble proteins, which exhibit spectra with central line widths
of 5–8 G [37–39]. Taken together the X-band CW line shapes suggest
that KL4 is in a monomeric and not aggregated form. Second, for each
site in SL-KL4, the ΔHpp values, which reﬂect the degree of motional
averaging, differ in each lipid environment. Speciﬁcally, in DPPC/POPG
lipid vesicles, the ΔHpp value is consistently higher, indicating slower
dynamics, than what is observed for the same position in POPC/POPG
lipid vesicles. This result reveals that site-speciﬁc spin label mobility
is dependent on the level of unsaturation in the phospholipids. Thisﬁnding is in agreement with our previous NMR studies of lipid acyl
chain dynamics and KL4 leucine sidechain dynamics by 2H NMR spec-
troscopy [27,28]. Mobility data from both NMR and SDSL indicate a
deeper penetration of KL4 in the more saturated lipid environment.
3.3. EPR line-shapes for n-doxyl lipids indicate that KL4 increases local order
in both DPPC/POPG and POPC/POPG lipid mixtures and penetrates more
deeply into DPPC/POPG bilayers
For each lipid system, samples containing native KL4 and spin-
labeled lipids were analyzed to determine the effects of KL4 on lipid
mobility as a function of peptide concentration. Data were collected
with liposome preparations that contain a ﬁnal concentration of
1mol% of n-doxyl-PSPC, where n=5, 7, or 12, or 1mol% TEMPO-PC rel-
ative to the bulk lipids (either 4:1 POPC/POPG or 4:1 DPPC/POPG). Em-
pirical line shape parameters were determined to assess changes in
mobility of the spin-label due to changes in the local environment.
Shown in Fig. 3A are the relative percentage changes inΔHpp, calculated
as 100 ∗ (ΔHpp(with peptide)− ΔHpp(without peptide)) / ΔHpp(without peptide),
for 5-PCSL, 7-PCSL, and 12-PCSL incorporated into DPPC/POPG and
POPC/POPG lipid mixtures as a function of KL4 addition; no changes in
ΔHpp values for TEMPO-PC were observed on addition of KL4 (data not
shown). For both lipid systems, the relative percentage change in
ΔHpp at positions 5 and 7 is seen to increase upon addition of KL4, con-
sistentwith a dose-dependent decrease in themobility of the doxyl spin
labels at these sites, revealing that the peptide is affecting the local en-
vironment at these positions and reducing motion of the lipids on the
nanosecond timescale. At position 12, the DPPC/POPG system showed
a dose-dependent decrease in mobility on addition of KL4, whereas at
this position in the bilayer, no changes in mobility were detected in
the POPC/POPG system upon KL4 addition. This result suggests again
that KL4 is partitioning more deeply into the DPPC/POPG bilayer and is
able to interact with the 12-PCSL, whereas in the POPC/POPG bilayer
the peptide partitions less deeply and thus does not affect mobility at
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mobile approaching a fast limit X-band spectrum, further characteriza-
tions ofmobility changes of the 12-doxyl spin labelweremade by calcu-
lating the ratio of the peak-to-peak amplitude of the central transition,
h(0), and the low ﬁeld transition, h(1) (Supplementary Figure S3). This
parameter, h(1)/h(0), has been shown to reﬂect conformational changes
in unfolded highly dynamic proteins [31,32]. With this analysis, a small
decrease in mobility can be detected in the POPC/POPG lipid environ-
ment, but it is substantially smaller than what is observed in DPPC/
POPG lipid environment, providing further evidence that the penetra-
tion depth of KL4 in these lipid systems is sensitive to the degree of
lipid fatty acid saturation.
3.4. Power saturation measurements using n-doxyl lipids show decreased
accessibility to both NiAA and O2 with increasing KL4, but the depth
parameter Φ is unchanged
To calibrate relative O2 and NiAA accessibility as a function of bilayer
depth in the two lipid systems and to determine the effects of KL4 oncollisions of these paramagnetic species with n-doxyl lipids, we per-
formed power saturation measurements on samples described above.
For both lipid systems in the absence of peptide, it is noteworthy that
Φ values for 5- and 7-doxyl are similar within error, and a slight differ-
ence in value is observed for 12-doxyl in these two systems (Fig. 3B). For
both lipid systems, upon addition of KL4,ΔP1/2 values decrease in a sim-
ilar manner for both O2 and NiAA at the 5-doxyl and 7-doxyl positions
(Supplementary Figure S4). However, the results show that the relative
frequency of collisions of NiAA at the 12-doxyl position in the different
lipid systems is differentially altered upon KL4 addition. For the POPC/
POPG lipid mixture, the values decrease in a dose dependent manner;
whereas for DPPC/POPG, values increase for higher KL4 concentrations.
On the other hand, while O2 collisions decrease for both systems upon
addition of KL4, the decrease is larger for the DPPC/POPG system. To-
gether, these results provide additional evidence that KL4 is likely
partitioning further into the DPPC-rich bilayers. Shown in Fig. 3B are
the calculated depth parameters, Φ, for the 5-, 7-, and 12-doxyl lipids
as a function of KL4 addition. Surprisingly,weﬁnd that thedepthparam-
eter, Φ, for the different spin labeled positions is minimally affected by
3217A.L. Turner et al. / Biochimica et Biophysica Acta 1838 (2014) 3212–3219the addition of peptide, with only slight changes seen for the 7-doxyl
and 12-doxyl positions in POPC/POPG bilayers. It appears that the rela-
tive changes in ΔP1/2 for both O2 and NiAA as a function of KL4 cancel
one another out when taking the natural logarithm of their ratios. Cau-
tion should bemade, however, that ifΠ (collision) values were to be re-
ported, there would be differences. The presence of KL4 changes both
the apparent penetration of NiAA and O2 in such a manner that the rel-
ative depth parameter is unaffected. Thus, the depth parameter value
remains strongly correlated with lipid acyl chain position in both lipid
systems, although the 5- and 7-doxyl positions have more similar
depthparameters in the POPC/POPGbilayers, particularly after the addi-
tion of KL4. These experiments serve as the necessary controls to cali-
brate a depth determination of SL-KL4 described below. The fact that
in the POPC/POPG system the 7-doxylΦ value differs upon the addition
of KL4 demonstrates the need for the lipid values to be calibrated in an
environment that contains a non-labeled protein when protein location
(discussed below) is to be investigated.
3.5. Power saturationmeasurements on SL-KL4 indicate that the peptide lies
in the plane of the lipid bilayers and with a slightly altered helical structure
to increase its amphipathic nature (hydrophobic moment); KL4 penetration,
helical pitch and orientation differ in the two lipid environments
Power saturation data for six KL4-P1 variants partitioned into DPPC/
POPG and POPC/POPG bilayers were collected with 2 mol% KL4-P1 rela-
tive to the lipids (i.e. 50:1 L/P). A plot of Φ as a function of spin-label
position in each of the lipid environments is shown in Fig. 4. For com-
parison, Φ values for the n-doxyl lipids at this peptide concentration
are shown as dashed lines. For both lipid systems, four of the six sites
are seen to partition to a depth range consistent with the locations ofA
5-Doxyl
7-Doxyl
12-Doxyl
POPC:POPG
Tempo-0.8
-0.4
0.0
0.4
Fig. 4. (Top)Φ values for KL4-P1 variants partitioning into (A) POPC/POPG and (B) DPPC/POPC
lipids (indicated by tags) at equivalent L/P ratios. (Bottom)Models of KL4 partitioning into (C) PO
the KL4-P1 constructs. The oxygens of the IAP N-Omoieties used in this study are color-coded w
measurements in POPC/POPG [20] and lipid coordinates are from model DPPC simulations [4
triplicate on differing days. Errors arise primarily from temperature ﬂuctuations.5- and 7-doxyl SL lipids in the lipid acyl region. In both lipid systems,
the periodic trends in Φ values are consistent with helices with period-
icity N3.6 that lie perpendicular to the bilayer normal. Although the gen-
eral structural features revealed by the power saturationmeasurements
are similar in the two lipid systems, some noteworthy differences in the
penetration depth and orientation of KL4 as a function of lipid environ-
ment are observed.
TheΦ values for sites 7, 8, and 9 are each larger in the DPPC system
compared to the POPC system, indicating that this region ismore deeply
inserted in the DPPC/POPC lipid environment. For example, L7P1 is near
the TEMPO position in POPC/POPG but near the 5-doxyl position
in DPPC/POPG. In addition for L9P1 the Φ value is similar to that of
12-doxyl-PSPC in DPPC/POPG, whereas L9P1 is positioned between 7-
and 12-doxyl in POPC/POPG. The trends in the Φ values for this region
of KL4 are consistent with the spin-label mobility parameter proﬁles
in Fig. 2. For sites 12–15 the results indicate a consistent penetration
level in both lipid systems with residues in the DPPC/POPG system
located between the 5- and 7-doxyl positions and those in POPC/
POPG having a depth slightly deeper than the 7-doxyl position,
thus indicating a helix that tilts into the bilayer in the unsaturated lipids.
For the DPPC/POPG system, results can be interpreted that the second
half of KL4 may kink back to the surface or, because theΦ values report
on the location of the spin-label and not the protein backbone; this ﬁnd-
ing may indicate that the side-chains are snorkeling to the bilayer sur-
face, which might be imposed by the closer packing of the saturated
lipids. We feel that the second interpretation is more likely given that
the spin-label mobility is more restricted compared to the unsaturated
system (Fig. 2); again a possible signature of a snorkeling spin-label and
consistent with the peptide partitioning very deeply into the lipid
bilayers. This is in contrast to classical amphipathic helices, whichB
5-Doxyl
7-Doxyl
12-Doxyl
DPPC:POPG
Tempo-0.8
-0.4
0.0
0.4
. Data were collected for a 50:1 L/P ratio. Lines indicateΦ values obtained for spin-labeled
PC-rich and (D)DPPC-rich regions. Partitioning depths are based onΦ values obtained for
ith respect to relative partitioning depth. The structural models for KL4 are based on NMR
4]. Error bars represent the standard deviations determined from samples measured in
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tition within the lipid headgroup region [36]. The overall pattern
of the Φ values is consistent with the non-canonical helical wheel
projections shown in Fig. 1B and C, with the resulting pattern indicative
of KL4 adopting an orientation that is parallel to the plane of the lipid
bilayers.
Using a peptidemodel derived from ssNMR constraints [20] and the
most likely conformers for IAP [40], models of KL4 in the different lipid
environments were developed to be consistent with the Φ values
(Fig. 4); in these models, the oxygen in the N–O moiety is color coded
to reﬂect the relative Φ value. Based on these models, we estimate
that the center of the KL4 helix is located 8–10 Å below the phosphates,
considerably deeper than what has been observed for amphipathic he-
lices which contain a more equal number of hydrophobic and hydro-
philic residues [36].
4. Discussion
The dynamic nature of PS, with turnover of PS lipid stores every
5–10 h, requires rapid trafﬁcking of lipids from tightly packed
multilamellar structures to the monolayer at the air/ﬂuid interface and
likely differentiation of fully saturatedDPPC frommonounsaturated lipids
andoxidized lipids. Lipid-rich PS relies on relatively low levels of lung sur-
factant proteins B (b0.2 mol%) to alter structure, dynamics, and phase
properties of the lipids. Peptidemimics of SP-B, such as KL4, are attractive
in surfactant replacement therapy as they are more chemically uniform,
less expensive and less immunologically reactive than exogenous lung
extracts. A current formulation, Lucinactant, containing the KL4 peptide
was recently approved for the treatment of ARDS, but how this relatively
simple peptide successfully restores lung compliance is not known.
Two conﬂictingmodels for KL4 partitioning into lipid bilayers, either
as a transmembrane helix or a helix lying in the plane of the bilayers,
have been used to describe how KL4 partitions into the lipid assemblies
and modulates their properties. We have studied the dynamics of the
lipids and several KL4 leucine sidechains in POPC/POPG (3:1) and
DPPC/POPG (4:1) environments via 2H and 31P NMR lineshape analyses
[27,28]. Our ﬁndings are consistent with an in-plane orientation of KL4
in the lipid bilayers, with deeper penetration occurring in DPPC:POPG
(4:1) bilayers than in POPC/POPG (3:1) bilayer. An in-plane membrane
bound orientation of KL4 is also consistent with previous studies using
peptides with hydrophobic/hydrophilic ratios similar to KL4 which
found that a transmembrane orientation is only favorable when the ly-
sines are positioned closer to the N- and C-termini rather than through-
out the peptide [41]. Our NMR studies also suggested that KL4 penetrates
much more deeply into the hydrophobic bilayer interior than typical
amphipathic helices, particularly in DPPC-rich membranes. This is likely
due to the higher hydrophobic residue content of KL4, which contains
only 24% charged/polar residues, relative to well-characterized amphi-
pathic antimicrobial peptides, which generally contain ~50% charged/
polar residues; a recent study of SP-B63–78, part of the sequence from
which KL4 was developed, also shows signiﬁcantly deeper peptide
partitioning relative to typical amphipathic helices [42]. However, our
NMR studies inferring the partitioning of KL4 are based onmeasurements
of lipid and peptide sidechain dynamics at a few select residues and do
not yield a high-resolution, quantitative model of the orientation and
partitioning depth of KL4 into the lipid bilayers.
In this study we utilized EPR to more directly and quantitatively
assay the partitioning depth of KL4 into lipid environments and its
effects on local lipid dynamics. To assay lipid speciﬁcity, we utilized
two lipid systems: POPC/POPG,which ismore typical of cell membranes,
and DPPC/POPG,which is used in the clinical formulation of KL4 and rep-
resents lipid species common in PS. We also chose temperature and pH
conditions [43] similar to native PS and utilized peptide concentrations
in the therapeutic range. Our results highlight both unique aspects of
PS, stemming from the preponderance of DPPC, and the complexity of
peptide/lipid interactions.4.1. EPR measurements conﬁrm that KL4 peptide partitions in a planar
orientation in fully hydrated lipid bilayers at physiologic temperature;
partitioning depth is lipid dependent
The EPR line shapes and power saturation data for SL-KL4 are in
agreement with a lipid-dependent partitioning model. Importantly,
the EPR data also point to an in-plane orientation of KL4 in the lipid
bilayers and a deeper penetration than is typically seen for amphipathic
helical peptides, many of which are antimicrobial membrane-
disrupting vehicles. The deeper penetration of KL4 has been previously
postulated and might play a critical role in its therapeutic activity. The
deep penetration of the peptide as well as its sensitivity to lipid compo-
sition may also explain some of the discrepancies in interpreting previ-
ous low-resolution assays of KL4 orientation in model membranes. A
model for KL4 partitioning and orientation in DPPC/POPG and POPC/
POPG bilayers is presented in Fig. 4 with the relative side chain depths
determined from our power saturation studies indicated. The peptide
backbone is modeled based on NMR data for KL4 in a POPC/POPG envi-
ronment, with a helical pitch depicted in Fig. 1B. Superimposing most
likely conformers of IAP [40] onto this structure leads to amodel of pep-
tide partitioning that is in very good agreement for the EPR measure-
ments in POPC/POPG. The radial distribution of SDSL-KL4 Φ values
observed in the DPPC/POPG environment does not show a good agree-
ment, suggesting that the structure of KL4 may be slightly altered in the
DPPC/POPG environment, with a higher helical pitch as depicted in
Fig. 1C. Measurements via NMR of the structure of KL4 in DPPC rich
lipid bilayers are ongoing.
4.2. Differential partitioning of KL4 into lipid bilayers leads to positive
curvature strain for bilayers containing only monounsaturated lipids and
stiffening of bilayers rich in DPPC
The SDSL lipid EPR line shapes collected in this study are sensitive to
nsec timescale motions; comparing them to previous NMR work [27],
which is sensitive to μsec timescale motions, allows us to distinguish
between changes in collective (μsec) and local (nsec) motions. A direct
comparison of EPR and 2H NMR order parameter changes at the 5 and
12 acyl chain positions in these lipid systems is provided in the Supple-
mentary information (S6). From the EPR line shapes, we are able to see a
decrease in the local motion of the acyl chains at the 5, 7 and 12 posi-
tions in DPPC/POPG bilayers and at the 5 and 7 positions in POPC/
POPG bilayers, consistent with KL4 partitioning more deeply into
DPPC/POPG lipid bilayers leading to increased local order further
down the lipid acyl chains. In contrast, the 2H NMR study showed
decreased motional averaging in DPPC/POPG lipids and increased mo-
tional averaging in POPC/POPG lipids on addition of KL4. Taken together,
these observations lead to a model in which the addition of KL4 in-
creases collective (μsec) motions in the POPC/POPG lipid bilayers and
decreases collective (μsec) motions in the DPPC/POPG lipid bilayers,
yet also decreases local (nsec)motion in both environments, again con-
sistentwith different peptide partitioning depths between the two lipid
bilayer systems. Changes in collective motions are also seen at a higher
percentage of KL4 than the changes in local motion (see Figure S6).
These observations suggest that the addition of KL4 leads to positive cur-
vature strain in the POPC/POPG lipid system but stiffens the DPPC/POPG
lipid bilayers.
5. Conclusion
Although KL4 possesses an amphipathic peptide sequence that is
helical in lipid bilayers, the relatively high percentage of leucine resi-
dues and unusual spacing of the lysine residues lead to a deeper average
penetration depth than is typically seen for amphipathic helices. The
peptide partitioning depth and orientation is sensitive to lipid acyl
chain saturation. Deep penetration in the plane of the lipid bilayers like-
ly leads to its sensitivity to lipid saturation and may underpin its
3219A.L. Turner et al. / Biochimica et Biophysica Acta 1838 (2014) 3212–3219unique ability to serve as a therapeutic substitute for SP-B in PS
replacement.
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